Pages that link to "Q114166152"
Jump to navigation
Jump to search
The following pages link to David Huntsman (Q114166152):
Displaying 47 items.
- ARID1A mutations in endometriosis-associated ovarian carcinomas (Q24610484) (← links)
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies (Q24619808) (← links)
- Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer (Q24633316) (← links)
- Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer (Q26780387) (← links)
- EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer (Q28188794) (← links)
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers (Q29619914) (← links)
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (Q30252854) (← links)
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study (Q33551425) (← links)
- Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies (Q33593016) (← links)
- Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers (Q33886925) (← links)
- Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes (Q36545843) (← links)
- Germline CDH1 deletions in hereditary diffuse gastric cancer families (Q37154264) (← links)
- The identification of Lynch syndrome in British Columbia (Q37420429) (← links)
- Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium (Q37639332) (← links)
- The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type. (Q38706007) (← links)
- Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (Q38720533) (← links)
- Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition (Q38889842) (← links)
- IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer (Q39587868) (← links)
- Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (Q42371458) (← links)
- ESR1 gene amplification in breast cancer: a common phenomenon? (Q42561463) (← links)
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas (Q42816041) (← links)
- Dose-Response Association of CD8 Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. (Q43924266) (← links)
- Benign serous ovarian tumour: a redefining moment? (Q46748797) (← links)
- Lynch syndrome-chasing a better ascertainment rate in British Columbia (Q46830782) (← links)
- Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. (Q47254055) (← links)
- MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. (Q52675313) (← links)
- BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. (Q53189566) (← links)
- Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (Q56337548) (← links)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (Q57261157) (← links)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (Q57261160) (← links)
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Q57261171) (← links)
- Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification? (Q57287243) (← links)
- Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer (Q59102270) (← links)
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk (Q59355837) (← links)
- Shared heritability and functional enrichment across six solid cancers (Q61118451) (← links)
- Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk (Q62583319) (← links)
- Shared heritability and functional enrichment across six solid cancers (Q64004349) (← links)
- Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines (Q90201636) (← links)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Q90242034) (← links)
- Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status (Q90589260) (← links)
- Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Q91553452) (← links)
- Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis (Q92127084) (← links)
- Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type (Q94684182) (← links)
- Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) (Q96590073) (← links)
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses (Q98158747) (← links)
- Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers (Q101216461) (← links)
- p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study (Q122925830) (← links)